查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542807

血漿治療的全球市場

Plasma Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年全球血漿治療市場將達7.825億美元

2023年全球血漿治療市場估計為4.763億美元，預計到2030年將達到7.825億美元，2023-2030年分析期間複合年成長率為7.3%。純 PRP 是本報告分析的細分市場之一，預計複合年成長率為 9.0%，到分析期結束時將達到 4.684 億美元。在分析期間，富含白血球的 PRP 片段的複合年成長率估計為 4.8%。

美國市場預估為1.292億美元，中國預期複合年成長率為6.7%

預計 2023 年美國血漿治療市場規模將達 1.292 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到1.198億美元，2023年至2030年複合年成長率為6.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.7% 和 5.9%。在歐洲，德國的複合年成長率預計為 5.5%。

全球血漿治療市場—主要趨勢與促進因素總結

從內部治癒：血漿療法的前景和過程

血漿療法，也稱為富血小板血漿（PRP）療法，是一種利用患者自身血液促進身體各部位癒合的醫療方法。這個過程從抽血開始，然後透過離心分離血小板和富含生長因子的血漿。這種濃縮血漿被注入受傷部位。血小板在血液凝固和組織修復中發揮重要作用，它們釋放的生長因子可促進細胞增殖、組織再生和癒合。由於這種療法具有促進復健和減少發炎的潛力，因此在整形外科、運動醫學和皮膚科等領域越來越受歡迎。

血漿療法如何應用於各醫學領域？

血漿療法由於其再生特性而被應用於各種醫學領域。在整形外科和運動醫學中，PRP注射用於治療網球肘和跟腱炎等慢性肌腱損傷，以及韌帶扭傷和肌肉拉傷等急性損傷。這些注射還可以幫助手術恢復，增強癒合過程並減少停機時間。在皮膚科中，PRP 用於使臉部回春、減少皺紋並改善皮膚紋理，這種手術通常稱為「吸血鬼臉部護理」。血漿療法的多功能性使其成為恢復醫學和美容醫學的寶貴工具，為患者提供自然有效的治療選擇。

血漿治療的研究與應用趨勢如何？

由於持續的研究和臨床進展，血漿治療領域正在不斷發展。一個重要的趨勢是擴大使用 PRP 與幹細胞療法和微針等其他治療方法相結合，以提高治療效果。研究人員也正在探索血漿療法在新領域的有效性，例如治療骨關節炎等退化性關節疾病和促進糖尿病患者創傷治療。 PRP製備技術的進步提高了治療的一致性和療效，使其更加可靠和有效。此外，人們越來越重視了解 PRP 的特異性成分，以及如何改變血小板和生長因子濃度以最佳化其適應各種疾病狀態。這些趨勢反映了血漿治療研究的動態性質，其目的是擴大 PRP 的應用範圍並改善患者的治療結果。

推動血漿治療市場成長的因素有哪些？

血漿治療市場的成長是由多種因素推動的，這些因素反映了對創新和有效治療的需求不斷成長。人們越來越認知到 PRP 治療的好處，加上其微創性和低副作用風險，吸引了更多的患者和醫療保健提供者。 PRP 製備和輸送方法的技術進步提高了治療的有效性和可靠性，進一步推動了其普及。血漿療法在整形外科、皮膚科和毛髮再生等各個醫學領域的廣泛應用正在促進市場成長。此外，再生醫學和個人化治療的不斷發展趨勢使得人們對 PRP 作為一種天然的、針對患者的治療方法越來越感興趣。新興市場不斷成長的醫療保健支出和不斷擴大的醫療基礎設施也支持了市場成長，使這些先進的治療方法更容易獲得。這些因素共同確保了血漿治療市場的強勁成長，並凸顯了其在現代醫療保健中的巨大潛力。

受訪企業範例（共38家）

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP14017

Global Plasma Therapy Market to Reach US$782.5 Million by 2030

The global market for Plasma Therapy estimated at US$476.3 Million in the year 2023, is expected to reach US$782.5 Million by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Pure PRP, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$468.4 Million by the end of the analysis period. Growth in the Leukocyte-Rich PRP segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$129.2 Million While China is Forecast to Grow at 6.7% CAGR

The Plasma Therapy market in the U.S. is estimated at US$129.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$119.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Plasma Therapy Market - Key Trends and Drivers Summarized

Healing from Within: The Promises and Processes of Plasma Therapy

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, is a medical treatment that utilizes the patient’s own blood to accelerate healing in various parts of the body. The process begins with a blood draw, from which the plasma, rich in platelets and growth factors, is isolated through centrifugation. This concentrated plasma is then injected into the injured or affected area. Platelets play a crucial role in clotting and tissue repair, and the growth factors they release can stimulate cell proliferation, tissue regeneration, and healing. This therapy is increasingly popular in fields like orthopedics, sports medicine, and dermatology for its potential to enhance recovery and reduce inflammation.

How Is Plasma Therapy Applied in Different Medical Fields?

Plasma therapy is utilized across a range of medical fields due to its regenerative properties. In orthopedics and sports medicine, PRP injections are used to treat chronic tendon injuries, such as tennis elbow and Achilles tendinitis, as well as acute injuries like ligament sprains and muscle strains. These injections can also aid in the recovery from surgeries, enhancing the healing process and reducing downtime. In dermatology, plasma therapy is employed for facial rejuvenation, reducing wrinkles, and improving skin texture through procedures commonly known as the “vampire facial.” Additionally, PRP is used in hair restoration treatments, promoting hair growth in patients experiencing hair loss. The versatility of plasma therapy makes it a valuable tool in both restorative and aesthetic medicine, offering patients a natural and effective treatment option.

What Are the Current Trends in Plasma Therapy Research and Applications?

The field of plasma therapy is continuously evolving, driven by ongoing research and clinical advancements. One significant trend is the increasing use of PRP in combination with other treatments, such as stem cell therapy and microneedling, to enhance therapeutic outcomes. Researchers are also exploring the efficacy of plasma therapy in new areas, such as treating degenerative joint diseases like osteoarthritis and promoting wound healing in diabetic patients. Advances in PRP preparation techniques are improving the consistency and potency of the treatments, making them more reliable and effective. Additionally, there is a growing emphasis on understanding the specific components of PRP and how different concentrations of platelets and growth factors can be optimized for various conditions. These trends reflect the dynamic nature of plasma therapy research, aiming to broaden its applications and improve patient outcomes.

What Factors Are Driving the Growth in the Plasma Therapy Market?

The growth in the plasma therapy market is driven by several factors, reflecting the increasing demand for innovative and effective medical treatments. Rising awareness of the benefits of PRP therapy, coupled with its minimally invasive nature and lower risk of side effects, is attracting more patients and healthcare providers. Technological advancements in PRP preparation and delivery methods are enhancing the efficacy and reliability of treatments, further boosting their popularity. The expanding applications of plasma therapy in diverse medical fields, including orthopedics, dermatology, and hair restoration, are contributing to market growth. Additionally, the growing trend towards regenerative medicine and personalized treatments is driving interest in PRP as a natural and patient-specific therapy. Increased healthcare spending and the expansion of medical infrastructure in developing regions are also supporting market growth, making these advanced treatments more accessible. These factors collectively ensure robust growth in the plasma therapy market, highlighting its significant potential in modern healthcare.

Select Competitors (Total 38 Featured) -

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Plasma Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Pure PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Leukocyte-Rich PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pure Platelet-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Leukocyte-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Plasma Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Dentistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION